There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian ...

Conservative Sen. Ted Cruz (Texas) on Monday pointed to what he called the “anti-capitalist” views of the 26-year-old man named as a person of interest in the investigation of the shooting ...

S.BIOMEDICS reported that TED-A9, an investigational cell therapy for Parkinson's disease, showed positive data during the Phase 1/2a trial.

S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell ...

Ted Cruz calls suspected UnitedHealthcare CEO shooter proof leftism is a “mental disease” Commenting on Luigi Mangione's embrace of climate-change causes, Cruz says support from "leftists" has ...

Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED) - 70% of patients treated ...

Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2 ...

After issuing the MAHA report, the administration published budget proposals to cut funding for the NIH by $17.0 billion, or 38%, the Centers for Disease Control and Prevention by $550 million, or ...

Glycemic Trends in Thyroid Eye Disease (TED) Patients Treated with Teprotumumab in 3 Clinical Trials Journal: Ophthalmology Published: 2024-01-22 DOI: 10.1016/j.ophtha.2024.01.023 Affiliations: 5 ...